Cholesterol Drug Testing Comes To A Halt

Merck Gives Up On Drug After FDA Ruling TRENTON, N.J. -- The drugmaker said Wednesday an advisory committee recommended ending the study of cholesterol drug MK-0524A, two months after the same scientists urged enrollment of more patients be put on hold. The halted study, called ACHIEVE, used... [read full story]